HOTH Rocket One Inc.

NEUTRAL Impact: 2/10 8-K
Horizon months Filed Jun 2, 2026 Processed 2d 23h ago SEC 0001213900-26-064177
8-K context-dependent: Items 8.01

Price Chart

Loading chart...

Executive Summary

Rocket One Inc. announced the appointment of Dr. Supriyo Bandyopadhyay as Lead Technical Advisor of AI Nanomagnetic Technology. This is a routine personnel announcement adding a prominent academic researcher to guide the company's nanomagnetic AI chip development for space and defense applications. No financial terms, revenue impact, or material business developments were disclosed.

Actionable Insight

This is a routine advisory appointment with no immediate financial or operational catalyst. Monitor future filings for progress on nanomagnetic chip fabrication milestones, government contract awards, or capital raises to fund the strategic pivot from biotech to space computing.

Key Facts

  • Appointed Dr. Supriyo Bandyopadhyay, a Commonwealth Professor at Virginia Commonwealth University, as Lead Technical Advisor of AI Nanomagnetic Technology.
  • Dr. Bandyopadhyay will guide technical development of the company's licensed nanomagnetic matrix multiplier architecture for orbital and defense computing.
  • No financial terms, compensation, equity grants, or material agreements were disclosed in the filing.
  • The company's biotechnology pipeline (HT-001, HT-KIT, HT-ALZ, GDNF program) continues under a wholly owned subsidiary, unchanged by this appointment.
  • The filing explicitly notes the licensed technologies are early-stage, have not been fabricated as integrated devices, and have not been validated in space environments.

Financial Impact

No financial impact disclosed; no revenue, costs, or deal value mentioned.

Risk Factors

  • Licensed nanomagnetic technologies are pre-fabrication and unvalidated in space environments — no commercial product exists.
  • Substantial additional capital required to fabricate, test, and qualify the technology; failure to raise could stall the pivot.
  • Company faces competition from larger, better-funded players in AI hardware, space, and defense computing.
  • Diligence milestones under VCU license agreements must be met or license rights could be lost.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-064177
Document: ea029323201ex99-1.htm0001213900-26-064177
Document: 0001213900-26-064177-index-headers.html0001213900-26-064177
Document: 0001213900-26-064177-index.html0001213900-26-064177
Document: 0001213900-26-064177.txt0001213900-26-064177
10 reports for HOTH
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+1▲ +14.12%May 27, 2026
Filters
Rows
Reports for HOTH — sortable, filterable
Type Now
Jun 3, 2026
2d ago
8-K
NEUTRAL ★ 2/10
$2.14 $1.98▼ −7.43%▼ −7.83%$1.98 (−7.43%)
Jun 3, 2026
2d ago
8-K
BEARISH ★ 5/10
$2.14 $1.98▲ +7.43%▲ +7.83%$1.98 (+7.43%)
Jun 3, 2026
2d ago
424B5
BEARISH ★ 6/10
$2.14 $1.98▲ +7.43%▲ +7.83%$1.98 (+7.43%)
Jun 2, 2026
2d ago
8-K
NEUTRAL ★ 2/10
awaiting T+1
May 28, 2026
8d ago
8-K
MIXED ★ 5/10
$1.70 $1.46▼ −14.12%▼ −14.36%$1.98 (+16.53%)
May 27, 2026
8d ago
424B5
BEARISH ★ 6/10
$1.70 $1.46▲ +14.12%▲ +14.36%$1.98 (−16.53%)
May 27, 2026
9d ago
8-K
NEUTRAL ★ 4/10
$1.36 $1.70▲ +25.00%▲ +24.45%$1.98 (+45.66%)
May 4, 2026
4w ago
8-K
BEARISH ★ 8/10
$0.7100 $0.7400▼ −4.23%▼ −2.84%$1.98 (−179.01%)
Apr 16, 2026
7w ago
8-K
NEUTRAL ★ 4/10
$0.7300 $0.7440▲ +1.92%▲ +2.11%$1.98 (+171.37%)
Apr 16, 2026
7w ago
424B5
BEARISH ★ 5/10
$0.7300 $0.7440▼ −1.92%▼ −2.11%$1.98 (−171.37%)
Showing 10 of 10

US Market Status

Market Open — Closes in 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access